UnitedHealthcare's Coverage Criteria for Upstaza (Eladocagene Exuparvovec) in Washington: What Counts as "Medically Necessary"?
Answer Box: UnitedHealthcare requires prior authorization for Upstaza (eladocagene exuparvovec) gene therapy, demanding genetic confirmation of DDC mutations, biochemical proof of AADC deficiency, and administration at a certified gene therapy center. If denied, Washington residents can appeal through internal review, then request external review through an Independent Review Organization (IRO)